Atlas Capital Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$282K Sell
695
-52
-7% -$21.1K 0.03% 343
2025
Q1
$372K Hold
747
0.05% 305
2024
Q4
$389K Hold
747
0.05% 291
2024
Q3
$462K Hold
747
0.07% 236
2024
Q2
$413K Sell
747
-100
-12% -$55.3K 0.05% 259
2024
Q1
$492K Hold
847
0.08% 220
2023
Q4
$450K Sell
847
-50
-6% -$26.5K 0.07% 239
2023
Q3
$454K Hold
897
0.07% 204
2023
Q2
$468K Buy
897
+375
+72% +$196K 0.07% 210
2023
Q1
$301K Hold
522
0.05% 282
2022
Q4
$287K Buy
522
+75
+17% +$41.3K 0.05% 268
2022
Q3
$227K Hold
447
0.04% 324
2022
Q2
$243K Hold
447
0.04% 340
2022
Q1
$264K Buy
447
+70
+19% +$41.3K 0.04% 304
2021
Q4
$252K Hold
377
0.04% 325
2021
Q3
$215K Hold
377
0.03% 333
2021
Q2
$190K Buy
377
+12
+3% +$6.05K 0.03% 364
2021
Q1
$167K Hold
365
0.03% 349
2020
Q4
$170K Buy
+365
New +$170K 0.04% 322
2020
Q3
Sell
-365
Closed -$132K 569
2020
Q2
$132K Hold
365
0.03% 362
2020
Q1
$104K Sell
365
-160
-30% -$45.4K 0.03% 358
2019
Q4
$171K Hold
525
0.04% 333
2019
Q3
$153K Sell
525
-200
-28% -$58.3K 0.05% 358
2019
Q2
$213K Sell
725
-150
-17% -$44.1K 0.07% 283
2019
Q1
$240K Sell
875
-48
-5% -$13.1K 0.09% 240
2018
Q4
$207K Buy
923
+48
+5% +$10.7K 0.08% 252
2018
Q3
$216K Hold
875
0.07% 282
2018
Q2
$185K Buy
875
+325
+59% +$68.6K 0.07% 279
2018
Q1
$114K Buy
+550
New +$114K 0.03% 329